Johnson & Johnson (JNJ) PT Lowered to $280; RBC Capital: 'Excessive Sell-Off Creates Defensive Opportunity'
Tweet Send to a Friend
RBC Capital analyst Trung Huynh lowered the price target on Johnson & Johnson (NYSE: JNJ) to $280.00 (from $290.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




